VisionPoint Advisory Group, LLC
- SEC CIK
- 0001750924
- Latest filing
- Jul 7, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by VisionPoint Advisory Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −16−100.0% | Sold out | Holders |
| Q3 2023 | 16 | $50 | <0.1% | +16 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −833−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q2 2022 | 12,500 | $8.00K | <0.1% | +2,500+25.0% | Added | Holders |
| Q1 2022 | 10,000 | $7.00K | <0.1% | +10,000 | New | Holders |